.png){kind=logo}
NURSl 307/l NURS307l Quizl 2l –l Pedsl |l WCUl (Latestl 2026/l 2027l Update)l 100%l Verifiedl Questionsl &l Answersl |l Gradel A
Q:l Whenl lowerl airwayl isl involvedl manifestationsl include:
Answer:
Signsl ofl alteredl airl exchangel suchl asl wheezing,l retractions,l crackles,l dyspnea,l tachypnea,l andl diminishedl breathl sounds
Q:l Whatl mayl bel thel firstl recognizedl indicatorl inl veryl youngl infantsl (<1l yearl old):
Answer:
Apneal (youngerl thanl 1l monthl old)
Q:l Virall sheddingl canl bel forl asl longl as:
Answer:
3l tol 8l days 4l weeksl forl childrenl withl weakenedl immunel systems
Q:l Withl progressionl ofl illness,l whichl symptomsl willl appear:
Answer:
Increasedl coughingl andl wheezing,l fever,l tachypneal andl retractions,l refusall tol nursel orl bottle-fed,l copiousl secretions
Q:l Withl severel illness,l whichl symptomsl willl appear:
Answer:
Tachypnea,l greaterl thanl 70l breaths/min,l listlessness,l apneicl spells,l alteredl airl exchangel (retractions,l crackles),l diminishedl breathl sounds
- / 4
Q:l RSV:l Diagnosticl evaluation
Answer:
Rapidl immunofluorescentl antibody-directl fluorescentl antibodyl stainingl orl enzyme-linkedl immunosorbentl assayl techniquesl forl RSVl antigenl directionl arel performedl onl nasopharyngeall secretions
Q:l RSVl Therapeuticl management
Answer:
-Mostl canl bel managedl atl home;l uncomplicatedl casesl arel treatedl withl adequatel fluidl intake,l airwayl maintenance,l andl medications -typicallyl resolvesl inl 5-7l days
Q:l Heatedl high-flowl nasall cannulal usedl forl andl benefits
Answer:
-Usedl forl hospitalizedl infantsl andl youngl childrenl whol arel atl riskl forl resp.l Failure -Improvesl functionall residuall capacity,l reducingsl thel workl ofl breathing
Q:l Fluidsl byl mouthl mayl bel contraindicatedl becausel of:
Answer:
Tachypnea,l weakness,l andl fatigue
Q:l Therapyl isl aimedl at:
Answer:
Increasingl airwayl hyperresonancel andl inflammationl andl promotingl adequatel fluidl intake
Q:l Ribavirin
Answer:
-(anl inhaledl antivirall agent) -Isl thel onlyl specificl therapyl approvedl forl hospitalizedl children
Q:l Palivizumabl (Synagis) 2 / 4
Answer:
-al humanizedl monoclonall antibody -Isl givenl atl thel onsetl ofl thel RSVl seasonl andl thenl monthlyl inl anl IMl injectionl orl IVl infusionl forl maxl ofl 5l dosesl tol preventl hospitalization
Q:l Candidatesl forl Palivizumabl (synagis)
Answer:
**prematurity,l chronicl lung,l ventl dependent,l muscularl dystrophy -Infantsl bornl beforel 29l weeksl ofl gestation -Infantsl bornl inl thel firstl yearl ofl lifel withl hemodynamicallyl significantl heartl disease;l (5l monthsl ofl injections -Infantsl inl thel firstl yearl ofl lifel forl preterml infantsl (<32l weeks)l withl chronicl lungl diseasel orl childrenl inl thel secondl yearl ofl lifel withl chronicl lungl diseasel whol requirel continuedl medicall intervention
Q:l Patientl outcomes:l Bronchiolitis
Answer:
O2l satl 90%l orl higher Respiratoryl ratel lessl thanl 60l bpm Adequatel orall intake
Q:l Nursingl carel management
Answer:
-Assignedl separatel roomsl orl groupedl withl otherl RSVl infectedl children -Contactl andl standardl precautions,l andl somel institutionsl usel droplet -Properl handl washingl isl essential -Staffl mustl bel carefull tol avoidl touchingl thel nasall mucosal orl conjunctiva -Infantsl willl havel difficultyl breathingl andl feeding -Parentsl arel taughtl howl tol instilll normall salinel dropsl intol thel naresl andl suctionl thel mucus -Parentsl canl offerl smalll amountsl ofl fluidsl (5-10l mL)l atl al time
Q:l Nursingl carel isl aimedl at:
- / 4
Answer:
Monitoringl oxygenl withl pulsel ox,l monitoringl IVl fluidsl orl NGl fluids,l monitoringl forl fever,l administeringl prescribedl medicationsl andl providingl informationl forl thel parentl andl family
Q:l RSVl -l whol isl mostl vulnerable
Answer:
1l yearl andl less
Q:l RSVl S/S
Answer:
lethargy,l poorl feeding,l irritability
Q:l SIDSl isl definedl as:
Answer:
thel suddenl deathl ofl anl infantl youngerl thanl 1l yearl ofl agel thatl remainsl unexplainedl afterl anl autopsy
Q:l SIDSl isl the...
Answer:
thirdl leadingl causel ofl infantl mortalityl inl thel US,l accountingl forl approx.l 8%l ofl alll infantl deathsl andl claimingl thel livesl ofl 3500l infantsl eachl year
Q:l SIDSl isl thel mostl commonl causel of...
Answer:
postneonatall infantl mortality,l accountingl forl 40-50%l ofl alll deathsl betweenl 1l monthl andl 1l yearl ofl age
Q:l SIDSl causativel factors
Answer:
-Maternall smoking
- / 4
.png)